Key result
This review discusses the pathophysiology, prevention, and management of silent cerebral embolism during atrial fibrillation transcatheter ablation to provide recommendations for reducing its incidence.
Why the study?
What are the mechanisms and prevention strategies for silent cerebral embolism during atrial fibrillation ablation?
What are the mechanisms and prevention strategies for silent cerebral embolism during atrial fibrillation ablation?
This review highlights the pathophysiology and potential preventive strategies for silent cerebral embolism, a major complication of atrial fibrillation ablation.
May warrant procedural vigilance in AF ablation; leaves open optimal prevention strategies pending prospective trials.
Although many efforts have been directed to improve atrial fibrillation transcatheter ablation safety, thromboembolism to the brain remains one of the major complications. In fact several studies have confirmed occurrence of silent cerebral embolic lesions by post-procedure magnetic resonance imaging. The present review will focus on the possible mechanisms leading to silent cerebral embolism in an attempt to provide recommendations holding the potential to reduce the incidence of this clinically relevant complication.
No takes yet. Share an insight, caveat, or question.
Anselmino et al. (2013) conducted a review in Atrial fibrillation. Atrial fibrillation transcatheter ablation was evaluated on Silent cerebral embolism. This review discusses the pathophysiology, prevention, and management of silent cerebral embolism during atrial fibrillation transcatheter ablation to provide recommendations for reducing its incidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: